NEWS
Mastering the hybrid cloud journey to business outcomes

By Mark Bennett, Senior Partner, EMEA Cloud Platforms Leader, IBM Consulting.

Read More
NEWS
Cloud First to Cloud Smart: A Strategic Shift

BY Rajesh Awasthi, Vice President & Global Head of Managed Hosting and Cloud Services, Tata Communications

Read More
NEWS
NaaS: Pulling the levers towards sustainable success

By Sherifa Hady, EMEA Channel Sales Director for Aruba.

Read More
NEWS
3 Steps to Build a Cloud Business Case That Gets Funded

By David Wright, Sr Director Analyst at Gartner.

Read More
NEWS
What lies ahead for MSPs in 2023?

By Chris McKie, VP, Product Marketing Security and Networking, Datto, a Kaseya company.

Read More
NEWS
Simplifying workflows and improving efficiency with cloud computing

By Mattias Andersson, Principal Developer Advocate at Pluralsight.

Read More
NEWS
Secure cloud transformation: Five foundational pillars

By David Guest, Solution Architect and Technology Evangelist at Kocho.

Read More

Videos

Jad Jebara, President and CEO of Hyperview, introduces the recently unveiled suite of features which are being added to the company’s DCIM solution, with the new carbon footprint reporting system, providing...
News and views from the recent DCA-organised Data Centre Transformation 2024 event.
News and views from the recent DCA-organised Data Centre Transformation 2024 event.
Iju Raj, Executive Vice President R&D and Simon Bennett, Director, Research and Innovation, both at AVEVA, discuss the importance of real time data analytics and how AI can help unlock access to this key...

News

El Capitan, powered by the AMD Instinct MI300A APU, becomes the second AMD supercomputer to surpass the Exascale barrier, placing #1 on the Top500 list.
IT teams urged to resolve ‘data delays’ as UK executives struggle to access and use relevant business data.
Channel partners can now use customised AI assistants, powered by ArrowSphere AI, to reinvent the way they manage business operations and engage with their customers.
The promise of AI is on every biopharma’s radar, but the reality today is that much of the industry is grappling with how to convert the hype into impact.